Rare diseases
Investigational molecules
Locations
350 Oyster Point Boulevard, 94080-1912, United States
Clinical research in hypertrophic cardiomyopathy includes both obstructive and non-obstructive forms, with attention to symptomatic HCM and left ventricular outflow tract obstruction. The studies focus on functional status, exercise capacity, and cardiac symptom burden.
Work in this area also includes pediatric hypertrophic cardiomyopathy, reflecting interest across age groups and disease presentations.
Cytokinetics Inc. runs clinical trials in conditions such as Hypertrophic cardiomyopathy, Heart failure with reduced ejection fraction, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability
FranceStudy of Aficamten for Children with Symptomatic Obstructive Hypertrophic Cardiomyopathy
IrelandStudy on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy
CzechiaStudy on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
DenmarkStudy Comparing Aficamten and Metoprolol for Adults with Symptomatic Hypertrophic Cardiomyopathy
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
